October is breast cancer awareness month and a new report from the University of North Carolina at Chapel Hill has revealed just how hard it can be to pin down the cost of care for this disease.
October is breast cancer awareness month and a new report from the University of North Carolina (UNC) at Chapel Hill has revealed just how hard it can be to pin down the cost of care for this disease.
Asbury Park Press reported that the average cost of care for breast cancer in women 65 years and older is $23,076 just for initial treatment, plus $2207 for continuing treatment. The problem is that while the Affordable Care Act has ensured mammograms are covered by health insurance plans for free, consumers instead now face higher out-of-pocket costs for health insurance coverage in general.
The study from UNC determined that the cost of care can vary greatly depending on what type of insurance patients have or if they have no insurance at all. Uninsured individuals pay $129 to $391 for a doctors visit compared with $65 to $246 for insured patients, and the costs for treatments are also more expensive for uninsured patients.
Read the full story from Asbury Park Press: http://on.app.com/1QTh0AB
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More